Integrated care experiences and out-of-pocket expenditures: a cross-sectional survey of adults receiving treatment for HIV and hypertension in Malawi.


Journal

BMJ open
ISSN: 2044-6055
Titre abrégé: BMJ Open
Pays: England
ID NLM: 101552874

Informations de publication

Date de publication:
12 02 2020
Historique:
entrez: 14 2 2020
pubmed: 14 2 2020
medline: 18 2 2021
Statut: epublish

Résumé

As HIV-positive individuals' life expectancy extends, there is an urgent need to manage other chronic conditions during HIV care. We assessed the care-seeking experiences and costs of adults receiving treatment for both HIV and hypertension in Malawi. A cross-sectional survey was conducted with HIV-positive adults with hypertension at a health facility in Lilongwe that offers free HIV care and free hypertension screening, with antihypertensives available for purchase (n=199). Questions included locations and costs of all medication refills and preferences for these refill locations. Respondents were classified as using 'integrated care' if they refilled HIV and antihypertensive medications simultaneously. Data were collected between June and December 2017. Only half of respondents reported using the integrated care offered at the study site. Among individuals using different locations for antihypertensive medication refills, the most frequent locations were drug stores and public sector health facilities which were commonly selected due to greater convenience and lower medication costs. Although the number of antihypertensive medications was equivalent between the integrated and non-integrated care groups, the annual total cost of care differed substantially (approximately US$21 in integrated care vs US$90 for non-integrated care)-mainly attributable to differences in other visit costs for non-integrated care (transportation, lost wages, childcare). One-third of those in the non-integrated care group reported no expenditure for antihypertensive medication, and six people in each group reported no annual hypertension care-seeking costs at all. Individuals using integrated care saw efficiencies because, although they were more likely to pay for antihypertensive medications, they did not incur additional costs. These results suggest that preferences and experiences must be better understood to design effective policies and programmes for integrated care among adults on antiretroviral therapy.

Identifiants

pubmed: 32051306
pii: bmjopen-2019-032652
doi: 10.1136/bmjopen-2019-032652
pmc: PMC7044935
doi:

Substances chimiques

Antihypertensive Agents 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

e032652

Subventions

Organisme : NIMH NIH HHS
ID : P30 MH058107
Pays : United States
Organisme : PEPFAR
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR000124
Pays : United States

Informations de copyright

© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Déclaration de conflit d'intérêts

Competing interests: None declared.

Références

BMJ Glob Health. 2018 Feb 19;3(1):e000535
pubmed: 29527342
Health Aff (Millwood). 2015 Sep;34(9):1514-22
pubmed: 26355053
Lancet. 2016 Jan 2;387(10013):61-9
pubmed: 26498706
Cochrane Database Syst Rev. 2006 Apr 19;(2):CD003318
pubmed: 16625576
JAMA. 2004 Jun 2;291(21):2616-22
pubmed: 15173153
J Acquir Immune Defic Syndr. 2017 Aug 1;75(4):472-479
pubmed: 28640065
Trop Med Int Health. 2017 Aug;22(8):926-937
pubmed: 28544500
Lancet Public Health. 2017 Sep;2(9):e411-e419
pubmed: 29253412
BMC Med. 2014 Jan 14;12:6
pubmed: 24423387
Health Policy. 2016 Apr;120(4):406-19
pubmed: 27108079
Lancet. 2013 Nov 2;382(9903):1525-33
pubmed: 24152939
BMJ Glob Health. 2019 Aug 21;4(4):e001475
pubmed: 31543984
Health Policy Plan. 2017 Nov 1;32(suppl_4):iv13-iv26
pubmed: 28666336
Lancet. 2010 Nov 20;376(9754):1785-97
pubmed: 21074253
AIDS. 2012 Jul 31;26 Suppl 1:S77-83
pubmed: 22781180
BMJ Glob Health. 2018 Jan 3;2(Suppl 3):e000519
pubmed: 29527334
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S40-53
pubmed: 25117960
Health Serv Insights. 2016 Oct 05;9:29-36
pubmed: 27721654
BMJ Glob Health. 2018 Feb 6;3(1):e000505
pubmed: 29564155
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S2-7
pubmed: 25117958
BMJ Glob Health. 2019 Jun 17;4(3):e001449
pubmed: 31321086
Lancet. 2013 Feb 16;381(9866):585-97
pubmed: 23410608
AIDS. 2018 Jul 1;32 Suppl 1:S93-S105
pubmed: 29952795
BMC Health Serv Res. 2016 Jan 27;16:32
pubmed: 26818827
Lancet Glob Health. 2018 Mar;6(3):e292-e301
pubmed: 29433667
BMC Complement Altern Med. 2016 Oct 24;16(1):410
pubmed: 27776505
BMC Public Health. 2016 Dec 12;16(1):1243
pubmed: 27955664
Health Policy Plan. 2017 Mar 1;32(2):257-266
pubmed: 28207046
Bull World Health Organ. 2017 Jul 1;95(7):537-539
pubmed: 28670019
Afr J Prim Health Care Fam Med. 2017 Feb 15;9(1):e1-e8
pubmed: 28235324
Health Aff (Millwood). 2016 Jul 1;35(7):1214-21
pubmed: 27385236
J Acquir Immune Defic Syndr. 2011 Aug;57 Suppl 2:S87-90
pubmed: 21857304
PLoS One. 2011;6(5):e20316
pubmed: 21629735
BMJ Glob Health. 2018 Feb 15;3(1):e000577
pubmed: 29527345
PLoS Med. 2018 Mar 7;15(3):e1002523
pubmed: 29513674
Trop Med Int Health. 2018 Aug;23(8):879-885
pubmed: 29808960
Lancet. 2018 Jan 13;391(10116):102-103
pubmed: 29353604
J Acquir Immune Defic Syndr. 2014 Sep 1;67 Suppl 1:S87-95
pubmed: 25117965
PLoS One. 2017 Feb 7;12(2):e0171284
pubmed: 28170413
BMC Fam Pract. 2017 Mar 23;18(1):46
pubmed: 28330453
Trans R Soc Trop Med Hyg. 2011 Nov;105(11):644-9
pubmed: 21924753
Healthc (Amst). 2015 Dec;3(4):270-6
pubmed: 26699356
Lancet. 2013 Feb 23;381(9867):690-7
pubmed: 23410609
J Acquir Immune Defic Syndr. 2009 Nov;52 Suppl 1:S14-6
pubmed: 19858929
AIDS. 2018 Jul 1;32 Suppl 1:S83-S92
pubmed: 29952794
Glob Health Epidemiol Genom. 2016 Nov 29;1:e19
pubmed: 29868211

Auteurs

Corrina Moucheraud (C)

Department of Health Policy and Management, Fielding School of Public Health, UCLA, Los Angeles, California, USA cmoucheraud@ucla.edu.

Matthew Hing (M)

Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.

Juliet Seleman (J)

Partners in Hope, Lilongwe, Malawi.

Khumbo Phiri (K)

Partners in Hope, Lilongwe, Malawi.

Florence Chibwana (F)

Partners in Hope, Lilongwe, Malawi.

Daniel Kahn (D)

Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.

Alan Schooley (A)

Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
Partners in Hope, Lilongwe, Malawi.

Agnes Moses (A)

Partners in Hope, Lilongwe, Malawi.

Risa Hoffman (R)

Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH